Cargando…

Pro: Alzheimer's disease and circadian dysfunction: chicken or egg?

Alzheimer's disease (AD) is a neurodegenerative disease that accounts for most cases of dementia. Besides progressive cognitive decline, circadian dysfunction is a prominent feature of AD. Circadian disruption is traditionally regarded as a downstream symptom of AD, but recent evidence suggests...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bedrosian, Tracy A, Nelson, Randy J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506939/ https://www.ncbi.nlm.nih.gov/pubmed/22883711 http://dx.doi.org/10.1186/alzrt128

Ejemplares similares

Con: Alzheimer's disease and circadian dysfunction: chicken or egg?
por: Moghekar, Abhay, et al.
Publicado: (2012)

Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?
por: Rafii, Michael S
Publicado: (2014)

Debates in Allergy Medicine: Does oral immunotherapy shorten the duration of milk and egg allergy? The pro argument
por: Pecora, Valentina, et al.
Publicado: (2018)

Debates in allergy medicine: baked egg and milk do not accelerate tolerance to egg and milk
por: Dang, Thanh D., et al.
Publicado: (2016)

Debates in allergy medicine: baked milk and egg ingestion accelerates resolution of milk and egg allergy
por: Leonard, Stephanie A.
Publicado: (2016)

Evidence of circadian rhythms in non-photosynthetic bacteria?
por: Soriano, María I, et al.
Publicado: (2010)

Is the risk of Alzheimer’s disease and dementia declining?
por: Langa, Kenneth M
Publicado: (2015)

Potential circadian and circannual rhythm contributions to the obesity epidemic in elementary school age children
por: Moreno, Jennette P., et al.
Publicado: (2019)

High adiposity: risk factor for dementia and Alzheimer’s disease?
por: Gustafson, Deborah R, et al.
Publicado: (2013)

Heterogeneity of Alzheimer’s disease: consequence for drug trials?
por: Devi, Gayatri, et al.
Publicado: (2018)

Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
por: Castello, Michael A, et al.
Publicado: (2014)

Functional illness in primary care: dysfunction versus disease
por: Williams, Nefyn, et al.
Publicado: (2008)

Debates in Allergy Medicine: Oral immunotherapy shortens the duration of milk and egg allergy - the con argument
por: Loh, Wenyin, et al.
Publicado: (2018)

Quality of Life as an outcome in Alzheimer's disease and other dementias- obstacles and goals
por: Riepe, Matthias W, et al.
Publicado: (2009)

Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature
por: Lathe, Richard, et al.
Publicado: (2014)

Pro- and anti-apoptotic CD95 signaling in T cells
por: Paulsen, Maren, et al.
Publicado: (2011)

Con: are we ready to translate Alzheimer’s disease-modifying therapies to people with down syndrome?
por: Head, Elizabeth, et al.
Publicado: (2014)

Research involving subjects with Alzheimer’s disease in Italy: the possible role of family members
por: Porteri, Corinna, et al.
Publicado: (2015)

PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales
por: Paterson, David L, et al.
Publicado: (2021)

Opening the Debate: How to Fulfill the Need for Physicians’ Training in Circadian-Related Topics in a Full Medical School Curriculum
por: Selfridge, Julia M, et al.
Publicado: (2015)

Is pathological aging a successful resistance against amyloid-beta or preclinical Alzheimer’s disease?
por: Murray, Melissa E, et al.
Publicado: (2014)

Advance directives as a tool to respect patients’ values and preferences: discussion on the case of Alzheimer’s disease
por: Porteri, Corinna
Publicado: (2018)

Inverse correlation between Alzheimer’s disease and cancer: implication for a strong impact of regenerative propensity on neurodegeneration?
por: Li, Jian-Ming, et al.
Publicado: (2014)

Have we learnt all we need to know from genetic studies - is genetics over in Alzheimer's disease?
por: Hampel, Harald, et al.
Publicado: (2013)

Should interventions to treat or prevent Alzheimer’s disease be tested in a population or as targeted treatment of highly selected study participants?
por: Ousset, Pierre Jean, et al.
Publicado: (2013)

PRO: Testing for ESBL production is necessary for ceftriaxone-non-susceptible Enterobacterales: perfect should not be the enemy of progress
por: Tamma, Pranita D, et al.
Publicado: (2021)

Digital health technologies and Alzheimer’s disease clinical trials: might decentralized clinical trials increase participation by people with cognitive impairment?
por: Leroy, Victoire, et al.
Publicado: (2023)

Dysfunctional problem-based learning curricula: resolving the problem
por: Lim, William K
Publicado: (2012)

Revisiting the link between cognitive decline and masticatory dysfunction
por: Lin, Chia-shu
Publicado: (2018)

PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemia
por: Taynton, Thomas, et al.
Publicado: (2022)

High-Cutoff Hemodialysis Therapy for Patients with Light Chain Cast Nephropathy and AKI Requiring Dialysis: PRO
por: Latcha, Sheron, et al.
Publicado: (2023)

Recent efforts to elucidate the scientific validity of animal-based drug tests by the pharmaceutical industry, pro-testing lobby groups, and animal welfare organisations
por: Bailey, Jarrod, et al.
Publicado: (2019)

Kidney Biopsy in a Pregnant Patient with Suspected Glomerular Disease: PRO
por: Oliverio, Andrea L., et al.
Publicado: (2023)

Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus
por: Maassen, J. A., et al.
Publicado: (2007)

Diastolic dysfunction and arterial stiffness: the chicken or the egg
por: Daemen, J.
Publicado: (2013)

Chicken or the egg: Warburg effect and mitochondrial dysfunction
por: Senyilmaz, Deniz, et al.
Publicado: (2015)

Circadian dysfunction and Alzheimer's disease – An updated review
por: Ahmad, Faizan, et al.
Publicado: (2022)

Implementation, context and complexity
por: May, Carl R., et al.
Publicado: (2016)

Lessons from Africa: developing a global human rights framework for tuberculosis control and prevention
por: Slagle, Tracy, et al.
Publicado: (2014)

Compensation of subjects for participation in biomedical research in resource – limited settings: a discussion of practices in Malawi
por: Nyangulu, Wongani, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ssahc401edbr0i6pluj082kf25